Open AccessThe influence of kinesio taping on trunk and lower extremity motions during different landing tasks: implications for anterior cruciate ligament injury
Author(s) -
Sheikhi Bahram,
Letafatkar Amir,
Hogg Jennifer,
NaseriMobaraki Esmaiel
Publication year - 2021
Publication title -
journal of experimental orthopaedics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 18
ISSN - 2197-1153
DOI - 10.1186/s40634-021-00339-w
Subject(s) - trunk , valgus , kinematics , anterior cruciate ligament , medicine , coronal plane , physical medicine and rehabilitation , jump , orthodontics , vertical jump , physical therapy , anatomy , physics , ecology , classical mechanics , quantum mechanics , biology
Purpose The purpose of the study was to investigate the influence of a 72‐h KT application on trunk and lower extremity kinematics during different landing tasks. Methods Twenty‐nine competitive male athletes participated in this study. The sum of knee valgus and lateral trunk lean, symmetry index (SI), and peak angles of lateral trunk lean, hip flexion, knee abduction and flexion were assessed for all participants during single‐leg drop landing (SLDL), single‐leg vertical drop jump (SLVDJ), vertical drop jump (DLVDJ), and double leg forward jump (DLFJ), at baseline and seventy‐two hours following KT application. Results The KT application resulted in more knee flexion and abduction, sum of knee valgus and lateral trunk lean as compared with the non‐KT condition during SLDL (P < 0.05). Nonetheless, there were no differences in SI, maximum angle of the lateral trunk lean during SLDL, SLVDJ, nor hip flexion, knee abduction, and flexion during DLVDJ, and DLFJ tasks (P > 0.05). Conclusions The research findings suggest that KT after 72‐h application may improve knee abduction and sum of knee valgus and lateral trunk lean during SLDL, knee flexion during SLDL and SLVDJ in individuals displaying risky single‐leg kinematics. Therefore, KT application may marginally improve high‐risk landing kinematics in competitive male athletes. Level of evidence Level III.